Dr. Yannuzzi has made numerous innovative and lasting contributions in imaging, drug development, and therapeutic modalities. He was the first to use oral non-steroid anti-inflammatory medication for the treatment of cystoid macular edema and developed an eye drop to treat this condition. He has described new diseases as well as new associations and manifestations of established entities and photosensitization.He has published over 400 scientific papers and 13 books, which have earned him respect and admiration in the ophthalmic-retinal community and retina specialists internationally. He is well recognized as a devoted and excellent educator, a superb clinical diagnostician, and a prolific organizer of retinal meetings worldwide. Dr. Yannuzzi is highly rated in 25 conditions, according to our data. His top areas of expertise are Central Serous Chorioretinopathy, Late-Onset Retinal Degeneration, Age-Related Macular Degeneration (ARMD), Adult-Onset Vitelliform Macular Dystrophy (AVMD), and Vitrectomy.

Philip Ferrone is an Ophthalmologist in Elmhurst, New York. Dr. Ferrone is highly rated in 23 conditions, according to our data. His top areas of expertise are Retinal Detachment, Late-Onset Retinal Degeneration, Age-Related Macular Degeneration (ARMD), Coats Disease, and Vitrectomy.

Dr. Spaide specializes in diseases of the retina and vitreous. His particular interests include retinal surgery, Macular Degeneration, Macular Holes, Macular Pucker, Diabetic Retinopathy, and intraocular inflammation. He has published more than 300 articles and 50 book chapters and 9 books about the diagnosis and treatment of Retinal Diseases. He has given lectures around the world.He has a remarkable number of “firsts” in retinal diseases including the development of autofluorescence imaging using a fundus camera and the first practical method to image deeper structures in the eye with optical coherence tomography. These imaging methods now are used around the world. He has described many new findings and diseases of the eye and helped develop many novel treatments. He has developed numerous surgical instruments that were named after him and holds patents for ophthalmic inventions.He is the recipient of the Richard and Hilda Rosenthal Foundation Award in the Visual Sciences, the Senior Honor Award from the American Society of Retinal Surgeons, and the Senior Achievement Award from the American Academy of Opthalmology and the Prix Soubrane de la Recherche en Ophthalmologie, Award of Merit from the Retina Society, the Henkind Award, Coscas Award, Nataraja Pillai Award, W. Richard Green MD Award, George Theodossiadis Award, Founders Award, American Society of Retinal Surgeons, Life Achievement Honor Award, and the American Academy of Ophthalmology. Dr. Spaide is highly rated in 16 conditions, according to our data. His top areas of expertise are Age-Related Macular Degeneration (ARMD), Late-Onset Retinal Degeneration, Central Serous Chorioretinopathy, Geographic Atrophy, and Vitrectomy.

Dr. Cooney is a practicing vitreoretinal surgeon who was previously an assistant professor of ophthalmology at Johns Hopkins University and later became the director of the Medical Retina Service, the Duke Center for Macular Degeneration, and the medical retina fellowship program from 2001 to 2005. He received a MBA degree from Kenan-Flagler Business School at the University of North Carolina, Chapel Hill.Dr. Cooney serves as a consultant and advisory board member for several pharmaceutical companies. In 1998, Dr. Cooney helped to establish InnoRx, an ophthalmic drug delivery and pharmaceutical company acquired by SurModics and served as a consultant from 2000 to 2002.Dr. Cooney’s clinical practice focuses on the medical and surgical treatment of vitreoretinal diseases, particularly age-related macular degeneration and diabetic retinopathy. He is actively involved in the clinical development of new diagnostic and therapeutic modalities for vitreoretinal disease and the training of residents and fellows.,Dr. Cooney helped establish InnoRx, an ophthalmic drug delivery and pharmaceutical company acquired by SurModics. Dr. Cooney is highly rated in 13 conditions, according to our data. His top areas of expertise are Late-Onset Retinal Degeneration, Age-Related Macular Degeneration (ARMD), Doyne Honeycomb Retinal Dystrophy, and Cone Dystrophy.

Dr. Paul T. Finger has collected or discovered the latest and most advanced medical technologies for the diagnosis and treatment of ocular tumors and eye cancer.With great respect for collaboration, he works closely with you, your referring doctor and his associated specialists to provide the most excellent care possible.The New York Eye Cancer Center was designed to be a responsive and caring environment, we strive to be your and your doctor's first choice for eye cancer care.Dr. Finger is the Director of Ocular Tumor Services at the Manhattan Eye, Ear and Throat Hospital and teaches residents from the New York University School of Medicine.A world-recognized expert in radiation and surgical techniques to conserve the eye and vision; Dr. Finger has pioneered the use of palladium-103 plaque radiation for choroidal melanoma, 3D and high-frequency ultrasound to image intraocular tumors, and created this world-renowned web site. Dr. Finger publishes in the major clinical journals and lectures frequently at local, national and international meetings. He graduated from Tulane Medical School, the Manhattan Eye, Ear and Throat Hospital, and then completed specialty training in treatment of ocular tumors and orbital diseases.Dr. Finger is certified by the American Board of Ophthalmology and is a Fellow of both the American College of Surgeons and the American Academy of Ophthalmology and sees patients from all over the world.Dr Finger was a principal investigator for The Collaborative Ocular Melanoma Study. He Chaired the Ophthalmic Oncology Task Force that wrote the 2014 consensus guidelines for plaque radiationt therapy of choroidal melanoma and retinoblastoma for The American Brachytherapy Society. Dr. Finger was the clinical director for the Plaque Radiation Therapy (Task Group 129) of the American Association for Physicists in Medicine (AAPM). Dr. Finger is Chair of the Ophthalmic Oncology Task Group of The American Joint Committee on Cancer (AJCC) - International Union Against Cancer (UICC). The AJCC-UICC has created a universal language (TNM-classification) commonly used around the world to describe eye cancer.Dr. Finger has a particular interest in melanoma of the choroid, ciliary body and iris. He has written extensively about new ways to detect and treat retinoblastoma, conjunctival melanoma, squamous carcinoma, metastatic cancer to the eye and orbital tumors.Dr. Finger has assembled a team to care for patients with eye tumors. By picking the best doctors from several institutions, his team includes the top radiation, medical and pediatric oncologists from several institutions in New York City.Dr. Finger has spent his career inventing and improving new methods of diagnosis and treatment for eye cancer:. Dr. Finger is highly rated in 10 conditions, according to our data. His top areas of expertise are Melanoma of the Eye, Metastatic Uveal Melanoma, Uveal Melanoma, Iridectomy, and Vitrectomy.

Celso Tello is an Ophthalmologist in New York, New York. Dr. Tello is highly rated in 5 conditions, according to our data. His top areas of expertise are Glaucoma, Ocular Hypertension (OHT), Cataract, Trabeculectomy, and Vitrectomy.

Mark Kupersmith is an Ophthalmologist in New York, New York. Dr. Kupersmith is highly rated in 52 conditions, according to our data. His top areas of expertise are Papilledema, Increased Intracranial Pressure, Pseudotumor Cerebri Syndrome, Optic Neuritis, and Thymectomy.

My practice focuses on cataract and refractive surgery using advanced technology, multifocal intraocular lenses and laser treatment to improve people's vision and make them less dependent on glasses. Each patient is unique and different approaches are applied depending on the individual's lifestyle needs. I deliver world class care and surgery to the patient in order to help them achieve their goals. Dr. Ellant is highly rated in 21 conditions, according to our data. His top areas of expertise are Interstitial Keratitis, Blepharitis, Eyelid Bump, and Cataract.

Ilan Cohen is an Ophthalmologist in Ridgewood, New York. Dr. Cohen is highly rated in 20 conditions, according to our data. His top areas of expertise are Cataract, Blepharitis, Allergic Conjunctivitis, and Glaucoma.

Brian Campolattaro is an Ophthalmologist in New York, New York. Dr. Campolattaro is highly rated in 17 conditions, according to our data. His top areas of expertise are Strabismus, Esotropia, Brown Syndrome, and Coloboma of Optic Papilla.

Louis Angioletti is an Ophthalmologist in New York, New York. Dr. Angioletti is highly rated in 10 conditions, according to our data. His top areas of expertise are Late-Onset Retinal Degeneration, Age-Related Macular Degeneration (ARMD), Geographic Atrophy, and Retinal Vein Occlusion.

Andrew Naing is an Ophthalmologist in New York, New York. Dr. Naing is highly rated in 9 conditions, according to our data. His top areas of expertise are Glaucoma, Eyelid Bump, Meibomianitis, and Age-Related Macular Degeneration (ARMD).

Kateki Vinod is an Ophthalmologist in New York, New York. Dr. Vinod is highly rated in 8 conditions, according to our data. Her top areas of expertise are Glaucoma, Pigment-Dispersion Syndrome, Ocular Hypertension (OHT), Trabeculectomy, and Cataract Removal.

Robert Ritch is an Ophthalmologist in New York, New York. Dr. Ritch is highly rated in 7 conditions, according to our data. His top areas of expertise are Glaucoma, Ocular Hypertension (OHT), Pigment-Dispersion Syndrome, Trabeculectomy, and Iridectomy.

Tsontcho Ianchulev is an Ophthalmologist in New York, New York. Dr. Ianchulev is highly rated in 7 conditions, according to our data. His top areas of expertise are Pigment-Dispersion Syndrome, Glaucoma, Ocular Hypertension (OHT), Cataract Removal, and Trabeculectomy.

Paul Sidoti is an Ophthalmologist in New York, New York. Dr. Sidoti is highly rated in 6 conditions, according to our data. His top areas of expertise are Glaucoma, Pigment-Dispersion Syndrome, Ocular Hypertension (OHT), Trabeculectomy, and Vitrectomy.

Rudrani Banik is an Ophthalmologist in New York, New York. Dr. Banik is highly rated in 6 conditions, according to our data. Her top areas of expertise are Papilledema, Optic Nerve Atrophy, Leber Hereditary Optic Neuropathy (LHON), and Increased Intracranial Pressure.

Susan Fromer is an Ophthalmologist in New York, New York. Dr. Fromer is highly rated in 24 conditions, according to our data. Her top areas of expertise are Glaucoma, Kallikrein Hypertension, Allergic Conjunctivitis, and Meibomianitis.

Naomi Goldberg is an Ophthalmologist in New York, New York. Dr. Goldberg is highly rated in 16 conditions, according to our data. Her top areas of expertise are Uveitis, Birdshot Chorioretinopathy, Scleritis, and Neuroretinitis.

John Seedor is an Ophthalmologist in New York, New York. Dr. Seedor is highly rated in 11 conditions, according to our data. His top areas of expertise are Fuchs Dystrophy, Interstitial Keratitis, Corneal Dystrophy and Perceptive Deafness, Corneal Transplant, and Trabeculectomy.

David C. Ritterband MD, FACS is a Professor of Ophthalmology at the Donald and Barbara Zucker School of Medicine at Hofstra/Northwell. Prior to joining Manhattan Eye, Ear and Throat Hospital (MEETH)/Northwell Eye Institute, he was a Professor of Ophthalmology at the Icahn School of Medicine at Mt Sinai and System Director of the Refractive Surgery Service for the Mount Sinai Health System. At MEETH he has assumed leadership of the Refractive Surgery division and the Laser Vision Correction Center and sees patients at the Manhattan Eye, Ear and Throat Hospital on 64th Street. Dr. Ritterband is a graduate of Duke University and received his medical degree at New York Medical College where he was elected to Alpha Omega Alpha, the national medical honor society. He completed his Ophthalmology Residency at New York Medical College where he was elected Chief Resident. He completed his Corneal and External disease and Refractive Surgery Fellowship at the University of Pittsburgh School of Medicine Eye and Ear Institute. He is a fellow of the American Academy of Ophthalmology and the American College of Surgeons. He is a past president of the Ocular Microbiology and Immunology Group and a long time Medical Board member of the Eye Bank for Sight Restoration in New York City, the world's first Eye Bank. In addition to maintaining a busy tertiary-care referral practice in New York City, Dr. Ritterband is a nationally recognized physician, scientist, and surgeon. He has published over 250 medical and scientific papers, book chapters, monographs, and research abstracts. He has lectured widely in the United States on cornea, cataract, and refractive surgery topics. His clinical and research interests include cornea transplantation, cataract surgery, ocular drug development, laser refractive surgery, and ocular infections. A committed teacher and mentor, he has trained over 50 clinical cornea fellows first at the highly regarded AUPO certified corneal fellowship program at the New York Eye and Ear Infirmary and continuing with the current AUPO corneal fellowship program at Manhattan Eye, Ear and Throat Hospital. Dr. Ritterband has received numerous awards including an Honor Award from the American Academy of Ophthalmology and has been named multiple times to New York Magazine's Best Doctors, Castle Connolly's Top Doctors, and the NY Times Magazine's Super Doctors. In addition, while at the New York Eye and Ear Infirmary he received 6 Resident Outstanding Teaching and Dedicated Service Awards. Dr. Ritterband is highly rated in 11 conditions, according to our data. His top areas of expertise are Cataract, Endophthalmitis, Interstitial Keratitis, Corneal Transplant, and Trabeculectomy.

Brian Marr, MD heads the Ophthalmic Oncology Service at the Harkness Eye Institute. He has comprehensive experience in the diagnosis, treatment, and management of ocular tumors including intraocular tumor resection, laser, radiation, and chemotherapy procedures. He has helped devise thousands of complex treatments for tumors of the eye, eyelid, orbit, and conjunctiva for his adult, children, and infant patients. Currently, Dr. Marr is a collaborator on a Columbia University clinical trial for a first-of-its-kind, new class of drug treatment for uveal melanoma.Dr. Marr is a board-certified ophthalmologist whose work has centered around ophthalmic oncology since 2000. One of the very few ocular oncologists trained in all aspects of eye cancer, Dr. Marr's clinical experience in treating these diseases is among the most extensive in the United States. His interest and experience in ophthalmic oncology began during an eight-year tenure in the Ocular Oncology Service at the Wills Eye Hospital in Philadelphia. There, he gained extensive experience treating intraocular tumors, and tumors of the eyelid, orbit, and conjunctiva in children and adults. It was there that Dr. Marr developed and improved many surgical procedures used to cure cancers of the eye, successfully treated thousands of patients, and helped their families though their battle with eye cancer. Next, Dr. Marr moved on to Memorial Sloan Kettering Cancer Center, where he remain for nine years, starting in 2008.Dr. Marr has some of the greatest experience with intra-arterial chemotherapy for treating retinoblastoma in the country, if not the world, as well as all other forms of retinoblastoma treatment. He has been a key member of many multidisciplinary surgical teams, treating advanced skull base tumors and complex facial skin lesions. He has developed a strong belief and treatment philosophy that the best research be used to help his patients, rather than his best patients be used to help his research. The field of ophthalmic oncology encompasses many rare conditions and his experience helps his patients get the best care and results as quickly as possible. Dr. Marr lectures and consults across the US and abroad, and has authored numerous research articles in the field of ocular oncology. He is the principal investigator in a first-in-class drug study for treating primary uveal melanoma, in an international, multi-center trial. He also volunteers his medical expertise in underserviced parts of the world, such as Nigeria and Indonesia, and has helped train physicians in more than 20 countries. Dr. Marr’s efforts as a contributor to ongoing education in ocular oncology have been recognized by the American Academy of Ophthalmology, where he now serves as chief editor of the Academy’s Oncology and Pathology’s One network. Dr. Marr is highly rated in 8 conditions, according to our data. His top areas of expertise are Retinoblastoma, Melanoma of the Eye, Metastatic Uveal Melanoma, Uveal Melanoma, and Vitrectomy.

Amilia Schrier is an Ophthalmologist in New York, New York. Dr. Schrier is highly rated in 7 conditions, according to our data. Her top areas of expertise are Cataract, Blepharitis, Meibomianitis, Cataract Removal, and Vitrectomy.

Dr. Jeffrey M. Liebmann is a Professor of Ophthalmology, Glaucoma Service Director, and Vice-Chair for the Department of Ophthalmology at Columbia University Medical Center.Dr. Jeffrey M. Liebmann graduated from Boston University School of Medicine, completed his ophthalmology residency at the State University of New York/Downstate Medical Center, and his glaucoma fellowship at the New York Eye and Ear Infirmary. Dr. Liebmann serves as Shirlee and Bernard Brown Professor, Vice-Chair, and Director of the Glaucoma Division of the Department Ophthalmology at Columbia University Medical Center. He is a fellow of the American Academy of Ophthalmology, Association for Research in Vision and Ophthalmology and American College of Surgeons. Dr. Liebmann is currently Editor-in-Chief of Journal of Glaucoma, a member of the Board of Governors of the World Glaucoma Association and Board of Directors of The Glaucoma Foundation and Secretary-Treasurer of the New York Glaucoma Society. Dr. Liebmann is a past-President of the World Glaucoma Association, American Glaucoma Society, and the New York Society for Clinical Ophthalmology and was co-founder of the New York Glaucoma Research Institute, the American Glaucoma Society Foundation and ASCRS Glaucoma Day.In addition to maintaining a busy tertiary-care referral practice in New York City, Dr. Liebmann is Principal Investigator for the NIH African Descent and Glaucoma Evaluation Study (ADAGES) and Ocular Hypertension Treatment Study (OHTS III) at Columbia University and is the author and/or co-author of more than 1000 medical and scientific papers, book chapters, and abstracts. He has lectured widely in the United States and abroad on glaucoma diagnosis and management. His current main areas of research interest include the causes of glaucoma, glaucoma progression, glaucoma surgery, ocular imaging, and neuroprotection. Dr. Liebmann is highly rated in 7 conditions, according to our data. His top areas of expertise are Glaucoma, Ocular Hypertension (OHT), Pigment-Dispersion Syndrome, Trabeculectomy, and Iridectomy.

Aakriti Shukla MD, MSc is an Associate Professor of Ophthalmology at CUMC and Attending Ophthalmologist at the New York Presbyterian Hospital. Dr. Shukla is a board-certified ophthalmologist and specializes in the medical and surgical management of glaucoma and cataracts. Her surgical expertise includes minimally invasive glaucoma surgery, traditional glaucoma surgery, glaucoma laser surgery, and cataract surgery.Dr. Shukla completed her undergraduate studies as a Trustee and Renaissance Scholar at the University of Southern California. She received her medical degree at Columbia University College of Physicians and Surgeons in New York City, where she was awarded a Doris Duke Clinical Research Fellowship and earned the Edith and Denton McKane Memorial Award for Outstanding Research in Ophthalmology. She completed her training as an ophthalmology resident and served as chief resident at Columbia University's Harkness Eye Institute. She earned a Master of Science degree at Columbia University’s Mailman School of Public Health in Patient-Oriented Research. She pursued further glaucoma subspecialty training at the Wilmer Eye Institute at Johns Hopkins University in Baltimore, MD. Prior to her appointment at Columbia University, she served as glaucoma faculty at the Wills Eye Hospital in Philadelphia, PA.Dr. Shukla has published numerous peer-reviewed articles, book chapters, and has been invited to speak nationally and internationally on her patient care and research. She serves on the editorial boards of Ophthalmology and Ophthalmology Glaucoma. She is continually inspired by her patients and aims to improve their quality of life while treating their glaucoma. Dr. Shukla is highly rated in 7 conditions, according to our data. Her top areas of expertise are Glaucoma, Ocular Hypertension (OHT), Pigment-Dispersion Syndrome, Trabeculectomy, and Cataract Removal.